1,000 patients to help unlock secrets of prolonged seizures
NCT ID NCT04204863
First seen Jun 17, 2026 · Last updated Jun 17, 2026
Summary
This study is gathering information from 1,000 adults who had a prolonged seizure (status epilepticus) to learn how doctors can better predict outcomes and tailor treatments. Researchers will look at medical records, lab results, and monitoring data from two Swiss hospitals. The goal is to improve care and reduce complications, but this study does not test any new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPTIC SEIZURES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cantonal Hospital Aarau (KSA)
RECRUITINGAarau, 5001, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Clinic for Intensive Care Medicine, University Hospital Basel
RECRUITINGBasel, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.